Focus
View

VERTEX PHARMACEUTICALS INC / MA

VRTX · FY2025

ALIGNED

CEO Package

$21.1M

Pay Ratio

—

Reshma Kewalramani

Pay reset -1.8% while TSR improved +13.6 pts

AbbVie Inc.

ABBV · FY2025

MISALIGNED

CEO Package

$32.5M

Pay Ratio

—

Robert A. Michael

Pay outran TSR by +62.0 pts

ABBOTT LABORATORIES

ABT · FY2025

ALIGNED

CEO Package

$24.2M

Pay Ratio

—

Robert B. Ford

Returns outran pay growth by +1.8 pts

CEOTotal Compensation — All Companies

VRTX$21.1MABBV$32.5MABT$24.2M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

ABBV carries the largest package at $32.5M, about 1.5x VRTX.
ABBV reads misaligned, while VRTX looks aligned.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

VRTX

Reshma Kewalramani

$21.1M

base salary8%
stock awards71%
non-equity incentive compensation19%
other compensation2%

ABBV

Robert A. Michael

$32.5M

base salary5%
stock awards41%
option awards10%
other compensation2%

ABT

Robert B. Ford

$24.2M

base salary6%
stock awards36%
option awards36%
non-equity incentive compensation8%
other compensation4%

Quick Comparison

CompanyCEOLatest YearTotal Comp
VERTEX PHARMACEUTICALS INC / MA(VRTX)Reshma Kewalramani2025$21.1M
AbbVie Inc.(ABBV)Robert A. Michael2025$32.5M
ABBOTT LABORATORIES(ABT)Robert B. Ford2025$24.2M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.